Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F4637
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $515,290
Award facts
- Contract value 100% obligated
- $515,289.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Medical Supply Chain, part of the Department of Defense, issued a $515,289.60 delivery order to Teva Pharmaceuticals USA, Inc. on April 15, 2026, for Adenovirus Type 4 vaccine. The order is firm fixed price with an ultimate completion date of April 29, 2026. Place of performance is Parsippany, NJ. No set-aside was used.
Quick answers
Who was awarded contract SPE2DP26F4637?
SPE2DP26F4637 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on April 15, 2026.
How much is contract SPE2DP26F4637 worth?
The government has obligated $515,290 on SPE2DP26F4637.
Is contract SPE2DP26F4637 an order under another contract?
Yes. SPE2DP26F4637 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F4637 competed?
The extent of competition for SPE2DP26F4637 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award